Portfolio Design Labs LLC Invests $435,000 in Cardinal Health, Inc. $CAH

Portfolio Design Labs LLC acquired a new stake in Cardinal Health, Inc. (NYSE:CAHFree Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,588 shares of the company’s stock, valued at approximately $435,000.

Other large investors have also modified their holdings of the company. Arkadios Wealth Advisors boosted its stake in Cardinal Health by 50.2% during the first quarter. Arkadios Wealth Advisors now owns 3,079 shares of the company’s stock worth $424,000 after buying an additional 1,029 shares during the period. Harbour Investments Inc. raised its position in Cardinal Health by 8.0% in the first quarter. Harbour Investments Inc. now owns 1,254 shares of the company’s stock valued at $173,000 after purchasing an additional 93 shares during the period. US Bancorp DE lifted its stake in Cardinal Health by 0.7% during the first quarter. US Bancorp DE now owns 44,114 shares of the company’s stock worth $6,078,000 after purchasing an additional 292 shares in the last quarter. IFG Advisory LLC boosted its position in shares of Cardinal Health by 7.0% during the first quarter. IFG Advisory LLC now owns 2,331 shares of the company’s stock worth $321,000 after buying an additional 153 shares during the period. Finally, PNC Financial Services Group Inc. grew its stake in shares of Cardinal Health by 3.3% in the first quarter. PNC Financial Services Group Inc. now owns 76,355 shares of the company’s stock valued at $10,519,000 after buying an additional 2,474 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on CAH shares. Argus raised their target price on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a report on Tuesday, November 4th. Mizuho lifted their price objective on shares of Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a report on Monday, November 3rd. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 8th. UBS Group boosted their price target on shares of Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a research note on Friday, October 31st. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average price target of $206.57.

Check Out Our Latest Analysis on Cardinal Health

Cardinal Health Price Performance

NYSE:CAH opened at $208.01 on Tuesday. Cardinal Health, Inc. has a 12 month low of $114.60 and a 12 month high of $214.93. The firm has a market capitalization of $49.42 billion, a PE ratio of 32.25, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72. The business’s fifty day moving average price is $178.77 and its 200 day moving average price is $163.90.

Cardinal Health (NYSE:CAHGet Free Report) last released its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.